Gain Therapeutics, Inc.
Gain Therapeutics, Inc. (GANX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
ganx · market cap & enterprise value · FMP · as of Jun 9, 2026
Core market cap & key metrics
As of Jun 9, 2026, Gain Therapeutics, Inc. (GANX) has a market cap — also referred to as its net worth or valuation — of $70,797,172, making it one of the top most valuable companies globally. Market Cap = $1.66 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Gain Therapeutics, Inc. (GANX) has a market cap — also referred to as its net worth or valuation — of $70,797,172 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Gain Therapeutics, Inc. reached its all-time high market cap of $662,702,569.382 on Jun 28, 2021. Comparing the Gain Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Gain Therapeutics, Inc. net worth vs peers and ask how Gain Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
GANX market cap · 6 questionsGain Therapeutics, Inc.'s net worth — measured as market capitalization — is $70,797,172 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$1.66 (price) × shares outstanding.